Zacks18h agoneutral
Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?HIMS first-quarter 2026 results are likely to benefit from Labs and branded weight loss medications even as higher costs and GLP-1 scrutiny linger.
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
232last 24h
1884last 7d
375🟢 bullish (7d)
178🔴 bearish (7d)
114publishers
Simply Wall St.3d agoneutral
Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price VolatilityWondering whether Hims & Hers Health at US$26.33 still offers value, or if the best entry points are already behind you? This article focuses squarely on what the current price may imply. The stock has been volatile, with a 7 day return of a 5.7% decline, a 30 day return of 37.6%, a year to date return of a 21.2% decline, and a 1 year return of a 46.8% decline, set against a 3 year return that is very large and a 5 year return of 166.0%. Recent coverage has highlighted how Hims & Hers Health...
